This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Dive Brief: A judge has denied the Federal Trade Commission’s request to block the $627 million takeover of Surmodics by the private equity company GTCR, Surmodics said Monday. The ruling removes one barrier to the deal. The acquisition remains subject to a restraining order that expires on Nov. 17 and to closing conditions, according to the announcement. Surmodi ...